REQUEST A DEMO
Total
USD $0.00
Search more companies

Dr. Vizdakne es Tarsa Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: DR. VIZDAKNE es TARSA Gyogyszerkiskereskedelmi Bt. Profile Updated: August 16, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Hungarian Download a sample report

Dr. Vizdakne es Tarsa Bt. is based in Hungary. The head office is in Mezotur. It operates in the Pharmacies and Drug Stores industry. Dr. Vizdakne es Tarsa Bt. was incorporated on December 13, 1993. The total number of employees is currently 5 (2023). From the latest financial highlights, Dr. Vizdakne es Tarsa Bt. reported a net sales revenue increase of 10.74% in 2022. Its’ total assets recorded a growth of 2.95%. Dr. Vizdakne es Tarsa Bt.’s net profit margin decreased by 2.62% in 2022.

Headquarters
Ujvaros VII. u. 13.
Mezotur; Jasz-Nagykun-Szolnok; Postal Code: 5400

Contact Details: Purchase the Dr. Vizdakne es Tarsa Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Dr. Vizdakne es Tarsa Bt. report to view the information.
Outstanding Shares:
Purchase the Dr. Vizdakne es Tarsa Bt. report to view the information.
Registered Capital:
Purchase the Dr. Vizdakne es Tarsa Bt. report to view the information.
Financial Auditors:
Purchase the Dr. Vizdakne es Tarsa Bt. report to view the information.
Incorporation Date:
December 13, 1993
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Dr. Vizdakne es Tarsa Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
10.74%
Total operating revenue
10.85%
Operating profit (EBIT)
-33.35%
EBITDA
-27.19%
Net Profit (Loss) for the Period
-34.75%
Total assets
2.95%
Total equity
10.56%
Operating Profit Margin (ROS)
-2.64%
Net Profit Margin
-2.62%
Return on Equity (ROE)
-6.63%
Quick Ratio
0.17%
Cash Ratio
0.15%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?